Israel Englander’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200
Closed -$27.8K 6745
2023
Q2
$27.8K Sell
200
-5,000
-96% -$642K ﹤0.01% 5586
2023
Q1
$473K Buy
5,200
+4,275
+462% +$580K ﹤0.01% 4643
2022
Q4
$127K Sell
925
-9,010
-91% -$3.05M ﹤0.01% 5501
2022
Q3
$8.61M Buy
+9,935
New +$6.23M 0.01% 2329
2022
Q2
Sell
-2,500
Closed -$1.59M 7719
2022
Q1
$1.59M Buy
+2,500
New +$1.58M ﹤0.01% 4085
2021
Q2
Sell
-9,169
Closed -$2.92M 7301
2021
Q1
$2.92M Buy
9,169
+785
+9% +$1.11M ﹤0.01% 3170
2020
Q4
$11.2M Buy
+8,384
New +$9.59M 0.01% 1604

Other funds holding CANO

Israel Englander's CANO Position: Q3 2023 in Review

Israel Englander sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 2,168 shares — an estimated $301K sold.

Israel Englander first reported a position in CANO in Q3 2020 and held it in 12 quarters. The position peaked at $65.6M in Q3 2021. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Israel Englander reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Israel Englander sold 2,168 Cano Health, Inc. shares in Q3 2023, an estimated $301K.
  • Israel Englander first reported a position in Cano Health, Inc. in Q3 2020 and held it in 12 quarters.
  • Israel Englander's Cano Health, Inc. position peaked at $65.6M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.